Position in DGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,911,119
-$718,557 QoQ
Shares Held
117,533
-10.1% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#99
of 1,095 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $550,105,949 across 22 Diagnostics & Research names. DGX ranks #10 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
433,146 | $98,233,181 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
139,499 | $69,939,218 | |
| 3 | ILMN |
Illumina, Inc.
|
356,183 | $62,627,656 | |
| 4 | DHR |
Danaher Corp /De/
|
235,913 | $44,936,708 | |
| 5 | SHC |
Sotera Health Co
|
2,206,457 | $39,164,611 | |
| 6 | A |
Agilent Technologies, Inc.
|
256,435 | $34,062,261 | |
| 7 | NTRA |
Natera, Inc.
|
102,398 | $27,795,937 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
140,692 | $27,184,508 |
All Filings in DGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,911,119 | 117,533 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,629,676 | 130,777 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,777,414 | 79,395 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,423,582 | 54,694 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,355,309 | 29,813 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,570,852 | 9,284 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $202,303 | 1,341 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $289,696 | 1,866 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $923,255 | 6,745 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,417,144 | 18,159 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $281,545 | 1,990 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,706,220 | 23,691 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,529,622 | 20,618 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,846,047 | 28,922 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,454,108 | 32,545 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,111,236 | 23,763 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,903,631 | 33,746 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,367,409 | 17,939 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,346,722 | 26,077 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,451,387 | 54,136 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,254,008 | 10,953 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,424,500 | 12,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,626,091 | 94,970 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||